Session information

Symposium

Symposium 20 When and how do we decide to treat non-culprit lesion after ACS from the pathological ?

Fri. Sep 20, 2019 9:40 AM - 11:10 AM Room 2 (Bldg4,1F)

Chair:Jiro Aoki(Mitsui Memorial Hospital), Marco Roffi(University Hospitals of Geneva, Switzerland)

Simultaneous interpretation

+Add all to schedule

[S20-K1] How to integrate the results of CULPRIT-SHOCK trial in clinical practice and what we shall expect from EURO-SHOCK trial

^○Roffi Marco (University Hospitals of Geneva, Switzerland)

[S20-K2] Should we treat non-culprit lesion after ACS: A pathologist’s view

^○Virmani Renu (CVPath Institute Inc., USA)

[S20-1] Physiological guidance to treat non-culprit lesions: Compare Acute and beyond

^○Pieter Smits (FESC, The Netherlands)

同通あり

[S20-2] When and how do we decide to treat non culprit lesion after ACS from the pathological ?

^○Francesco Prati^1,2 (1.Cardiology Unit, San Giovanni, Hospital , Rome, 2.CLI Foundation – Rome)

同通あり

[S20-3] What is the optimal timing for revascularization for non-culprit lesion?

^○Capodanno Davide (Cardiology, AOU Policlinico-Vittorio Emanuele, University of Catania)

同通あり

×

Authentication

×

Please log in with your participant account.
» Participant Log In